Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers
Guido Claessen, Andre La Gerche, Thibault Petit, Hilde Gillijns, Jan Bogaert, Mathias Claeys, Steven Dymarkowski, Piet Claus, Marion Delcroix, Hein Heidbuchel
The Journal of Heart and Lung Transplantation | ELSEVIER SCIENCE INC | Published : 2017
M.D. has served as investigator, speaker, consultant or steering committee member for Actelion, Bayer, Eli Lilly, GlaxoSmithKline, Pfizer and United Therapeutics, and has received research grants from Actelion, GlaxoSmithKline and Pfizer. H.H. is on the speakers' bureau and advisory board of Bayer, Boehringer-Ingelheim, Daiichi Sankyo, Bristol-Myers Squibb, Pfizer, Merck, Biotronik and St. Jude Medical.This study was funded by a grant from the Fund for Scientific Research Flanders (FWO), Belgium. A.L.G. was funded by a Career Development Fellowship from the National Health and Medical Research Council and National Heart Foundation of Australia (NHMRC and NHF).